amifampridine phosphate

amifampridine phosphate (FIRDAPSE) is an FDA-listed pharmaceutical active ingredient. Associated with CATALYST PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.

FIRDAPSE is a marketed brand name for amifampridine phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

amifampridine phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.